iCAD, Inc. (NASDAQ: ICAD)

iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions, enables healthcare professionals to identify pathologies and pinpointing cancer earlier. The company provides a broad range of high-performance, upgradeable CAD systems and workflow solutions for mammography, Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). iCAD’s solutions are available in more than 2,200 healthcare centers worldwide. For further information, visit the Company’s web site at www.icadmed.com.